Please login to the form below
Novarits
This page shows the latest Novarits news and features for those working in and with pharma, biotech and healthcare.
New Pfizer boss shakes up leadership team
The move reflects a wider trend in big pharma, with Novarits and GlaxoSmithKline hiring their own digital leaders, GSK appointing Walmart’s Karenann Terrell as its chief digital and technology officer
Latest news
-
Novartis cuts manufacturing jobs in Switzerland and UK
Novarits’ UK country president Haseeb Ahmad said the decision was not linked to Brexit, and that "Novartis remains committed to the UK and believes that the UK is a world leader
-
Novartis plans digital therapeutics for schizophrenia and MS
Will work with Pear Therapeutics on a prescription software range
-
NICE gives Novartis' Lucentis a final no for diabetic macular oedema
NICE has refused to back Novarits' eye drug Lucentis (ranibizumab), saying its use to treat diabetic macular oedema was not a good use of NHS resources.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Country report: The healthcare market in Brazil
1. Pfizer. US. 666.1. 1, 932.2. 2, 160.7. 2. Novarits. Switzerland.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Novartis appoints new comms chief
Michael Willi replaces Michele Galen. Swiss pharma company Novarits has named Michael Willi as its new global head of communications, effective June 1.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Amgen gets block on sales of Repatha rival in Germany
- Congress is in session – how companies are boosting their impact and engagement
- The state of pharma customer experience
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
